ZenBio Licenses An Important Cell Line From Harvard To Drive Metabolic Disease Research
Links shared publicly online about this topic.
- 1,323total visits
ZenBio Licenses An Important Cell Line From Harvard To Drive Metabolic Disease Research
ZenBio announce that they will be a commercial source for the popular murine 3T3-L1 cell line, which has been fundamental in metabolic disease research for 30 years. Originally derived from Swiss
View full resource at medicalnewstoday.com
Tags: Metabolic, Disease and Condition
Most Recently Shared on March 11, 2010 at 5:07 am By:
ZenBio Licenses An Important Cell Line From Harvard To Drive Metabolic Disease Research http://mnt.to/3yKW #biology
Also Shared By:
Advertisement
medical_tweets
@medical_tweets
ZenBio Licenses An Important Cell Line From Harvard To Drive Metabolic Disease Research ZenBio announce that they wil.. http://bit.ly/bYj43N
1 year ago...